HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S K Lam Selected Research

Therapeutics

9/2006Stability of E-cadherin methylation status in gastric mucosa associated with histology changes.
4/2006Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation.
10/2004Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up study.
3/2003Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial.
2/2003Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection.
12/2002One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.
4/2002One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies.
12/2001Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection.
9/2001An evaluation of the PyloriTek test for the diagnosis of Helicobacter pylori infection in Chinese patients before and after eradication therapy.
6/2001Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S K Lam Research Topics

Disease

21Infections
04/2006 - 02/2000
10Gastroesophageal Reflux (GERD)
05/2007 - 03/2000
10Ulcer
01/2005 - 08/2000
8Duodenal Ulcer (Curling's Ulcer)
01/2005 - 02/2000
8Stomach Neoplasms (Stomach Cancer)
11/2001 - 03/2000
7Peptic Ulcer (Peptic Ulcers)
08/2006 - 08/2000
6Neoplasms (Cancer)
07/2010 - 06/2001
6Dyspepsia (Indigestion)
09/2006 - 02/2001
4Inflammation (Inflammations)
10/2001 - 08/2000
3Aortic Diseases
11/2008 - 01/2007
3Heartburn (Pyrosis)
05/2007 - 12/2002
3Chest Pain (Chest Pains)
09/2003 - 03/2002
3Hemorrhage
07/2002 - 08/2000
2Bites and Stings (Sting)
02/2017 - 04/2003
2Constipation
02/2007 - 09/2005
2Gastritis
04/2006 - 09/2001
2Asthma (Bronchial Asthma)
09/2003 - 08/2000
2Stomach Ulcer (Gastric Ulcer)
09/2001 - 08/2000
2Colitis
08/2001 - 01/2001
1acute flaccid myelitis
01/2022
1Psoas Abscess
10/2013
1Abscess
10/2013
1Hypertension (High Blood Pressure)
04/2008
1Colonic Neoplasms (Colon Cancer)
05/2007
1Carcinogenesis
04/2006
1Pancreatitis
03/2004
1Gallstones (Gallstone)
03/2004
1Colorectal Neoplasms (Colorectal Cancer)
11/2003
1Deglutition Disorders (Dysphagia)
09/2003
1Bronchitis
09/2003
1Pneumonia (Pneumonitis)
09/2003
1Hoarseness
09/2003
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
12/2002
1Pyogenic Liver Abscess
06/2002
1Hantavirus Infections
12/2001
1Cholangitis
10/2001

Drug/Important Bio-Agent (IBA)

9AcidsIBA
05/2007 - 02/2000
9Clarithromycin (Biaxin)FDA LinkGeneric
01/2006 - 02/2000
7Amoxicillin (Wymox)FDA LinkGeneric
01/2006 - 11/2000
7Metronidazole (Metric)FDA LinkGeneric
03/2003 - 02/2000
6Proteins (Proteins, Gene)FDA Link
07/2010 - 06/2001
6Omeprazole (Prilosec)FDA LinkGeneric
01/2005 - 08/2000
6Lansoprazole (Prevacid)FDA LinkGeneric
02/2004 - 02/2000
5Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2003 - 02/2001
3Cadherins (E-Cadherin)IBA
09/2006 - 06/2001
3Rabeprazole (Aciphex)FDA Link
01/2006 - 12/2001
2Proton Pump InhibitorsIBA
06/2003 - 10/2002
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2003 - 09/2001
2Anti-Bacterial Agents (Antibiotics)IBA
03/2003 - 06/2002
2ranitidine bismuth citrate (Tritec)FDA Link
12/2002 - 03/2001
2EnzymesIBA
03/2002 - 10/2001
2Immunoglobulin G (IgG)IBA
03/2002 - 08/2000
2InterleukinsIBA
10/2001 - 07/2000
2Caspase 3 (Caspase-3)IBA
09/2001 - 01/2001
2Messenger RNA (mRNA)IBA
09/2001 - 09/2001
2Indomethacin (Indometacin)FDA LinkGeneric
09/2001 - 03/2000
2Sulfonic AcidsIBA
08/2001 - 01/2001
2sym-trinitrobenzeneIBA
08/2001 - 01/2001
1Antivenins (Antivenoms)IBA
02/2017
1Methicillin (Metin)FDA Link
10/2013
1Human immunodeficiency virus 1 reverse transcriptaseIBA
07/2010
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2010
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
05/2007
1tegaserod (Zelnorm)FDA Link
02/2007
1Cisapride (Propulsid)FDA Link
08/2006
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
09/2005
1GuaiacIBA
11/2003
1CI 22IBA
10/2003
1cyclo(Arg-Pro) (CI 4)IBA
03/2003
1Rifabutin (Ansamycin)FDA Link
02/2003
1Levofloxacin (Levaquin)FDA Link
02/2003
1TabletsIBA
01/2003
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
07/2002
1Vasopressins (Vasopressin)IBA
07/2002
1Octreotide (Sandostatin)FDA LinkGeneric
07/2002
1Furazolidone (Furoxone)FDA Link
04/2002
1ImmunosorbentsIBA
03/2002
1AntigensIBA
12/2001
1Therapeutic UsesIBA
11/2001
1NF-kappa B (NF-kB)IBA
11/2001
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
11/2001
1triptolideIBA
11/2001
1MitogensIBA
10/2001
1Phosphotransferases (Kinase)IBA
10/2001
1ProstaglandinsIBA
10/2001
1Mitogen-Activated Protein KinasesIBA
10/2001
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2001
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
10/2001
1Interleukin-1beta (Interleukin 1 beta)IBA
10/2001

Therapy/Procedure

16Therapeutics
09/2006 - 02/2000
4Aftercare (After-Treatment)
02/2003 - 08/2000
3Stents
11/2008 - 01/2007
1Nerve Transfer
01/2022
1Length of Stay
10/2013
1Cholecystectomy
03/2004
1Endoscopic Sphincterotomy
03/2004
1Diet Therapy (Therapy, Diet)
11/2003
1Surgical Instruments (Clip)
04/2003
1Drug Therapy (Chemotherapy)
03/2003
1Decompression
10/2001